Starting in 1996, Alexa Internet has been donating their crawl data to the Internet Archive. Flowing in every day, these data are added to the Wayback Machine after an embargo period.
On May 18, AIDS vaccine advocates worldwide mark World AIDS Vaccine Day by acknowledging all who work tirelessly to find a safe and effective AIDS vaccine, the world's best hope for ending the AIDS pandemic.
Originally aired as part of BBC World’s Kill or Cure? series, this four-minute documentary features AIDS specialists, researchers, and community workers discussing the impact of HIV/AIDS on their communities and their efforts to find a solution to the epidemic.
Despite the international community's best efforts, the HIV pandemic continues unabated. In 2006, more than
39 million people were living with HIV worldwide. Over four million people became newly infected with HIV and an
estimated 2.8 million lost their lives to AIDS.
A vaccine is a substance that is introduced into the body to prevent infection or to control disease due to a
certain pathogen (any disease-causing organism, such as a virus, bacterium or parasite); the vaccine 'teaches' the
body how to defend itself against a pathogen by creating an immune response.
In an opinion piece published in the Wall Street Journal, IAVI President and CEO Seth Berkley challenges the pessimism surrounding recent AIDS vaccine media coverage and states that there are sound scientific reasons to believe we can create a vaccine against AIDS.
New Market Tax Credit Helps Finance IAVI AIDS Vaccine Development Lab Construction
The National Community Fund I, LLC and Greystone CDE, LLC have chosen IAVI’s new AIDS Vaccine Development Laboratory to be the recipient of a New Markets Tax Credit, a financing program designed to spur investment in businesses and create jobs in low-income communities.
IAVI and CHAVI Team Up on AIDS Vaccine Development
The Center for HIV/AIDS Vaccine Immunology has partnered with IAVI to research four key biological questions hindering the development of an AIDS vaccine.
On March 25, the U.S. National Institutes of Health gathered leaders in HIV vaccine research and development to evaluate the current state of the AIDS vaccine field and determine a course for the future.
A male circumcision study indicates no HIV-protection for women; another indicates reduction in genital infections. Two herpes suppression trials show treating genital herpes doesn’t reduce risk of HIV infection.
New York: